Page last updated: 2024-08-25

zoledronic acid and Adenocarcinoma of Lung

zoledronic acid has been researched along with Adenocarcinoma of Lung in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (66.67)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Wu, W; Yu, G; Zhang, C; Zhang, M1
Mi, J; Xu, Q; Zhang, Y1
Imamura, Y; Matsuda, S; Sano, K; Umeda, Y; Yoshida, H; Yoshimura, H1
Bahleda, R; Escudier, B; Gueutin, V; Izzedine, H; Rouvier, P; Soria, JC; Varga, A1
Gehi, D; Rubin, CD; Tachibana, I1
Chang, HJ; Chang, JW; Li, YY; Liu, YC; Su, SP; Tsai, MC; Wang, CH; Yeh, KY1

Other Studies

6 other study(ies) available for zoledronic acid and Adenocarcinoma of Lung

ArticleYear
Camrelizumab plus Zoledronic Acid Showed Sustained Efficacy in a Patient with Cranial and Spinal Metastases from Lung Adenocarcinoma.
    Iranian journal of immunology : IJI, 2021, Volume: 18, Issue:2

    Topics: Adenocarcinoma of Lung; Antibodies, Monoclonal, Humanized; Brain Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Spinal Neoplasms; Zoledronic Acid

2021
Lung adenocarcinoma presents with diffuse bone metastasis.
    Thoracic cancer, 2021, Volume: 12, Issue:19

    Topics: Adenocarcinoma of Lung; Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Gefitinib; Humans; Lung Neoplasms; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Zoledronic Acid

2021
Mandibular metastasis as the first clinical indication of occult lung adenocarcinoma with multiple metastases: A case report.
    Medicine, 2018, Volume: 97, Issue:15

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged, 80 and over; Antineoplastic Agents; Biopsy; Bone Density Conservation Agents; Diagnosis, Differential; Diphosphonates; Female; Gefitinib; Humans; Imidazoles; Immunohistochemistry; Lung; Lung Neoplasms; Mandible; Mandibular Neoplasms; Neoplasm Grading; Neoplasm Staging; Quinazolines; Thyroid Neoplasms; Treatment Outcome; Zoledronic Acid

2018
Acute tubular necrosis associated with mTOR inhibitor therapy: a real entity biopsy-proven.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24, Issue:9

    Topics: Acute Kidney Injury; Adenocarcinoma; Adenocarcinoma of Lung; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Carcinoma, Renal Cell; Cisplatin; Cyclophosphamide; Diphosphonates; Doxorubicin; Female; Glutamates; Guanine; Humans; Imidazoles; Indoles; Interferons; Kidney Tubules; Lung Neoplasms; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Middle Aged; Necrosis; Nephrectomy; Pemetrexed; Prednisone; Pyrroles; Sunitinib; TOR Serine-Threonine Kinases; Vincristine; Zoledronic Acid

2013
Treatment of Hypertrophic Osteoarthropathy With Underlying Pulmonary Adenocarcinoma Using Zoledronic Acid.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2015, Volume: 21, Issue:6

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Analgesics, Opioid; Bone Density Conservation Agents; Diphosphonates; Glucocorticoids; Humans; Imidazoles; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Osteoarthropathy, Secondary Hypertrophic; Pain Management; Pain Measurement; Pneumonectomy; Treatment Outcome; Zoledronic Acid

2015
Zoledronic acid induces cell-cycle prolongation in murine lung cancer cells by perturbing cyclin and Ras expression.
    Anti-cancer drugs, 2011, Volume: 22, Issue:1

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Cyclins; Diphosphonates; Diterpenes; Down-Regulation; E2F Transcription Factors; Imidazoles; Lung Neoplasms; Mevalonic Acid; Mice; Mice, Inbred BALB C; Phosphorylation; Protein Transport; ras Proteins; Retinoblastoma Protein; Zoledronic Acid

2011